远大控股(000626) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥17,517,695,932.01, representing a 2.58% increase compared to ¥17,076,716,532.60 in the same period last year[6] - Net profit attributable to shareholders was ¥15,654,959.42, a significant increase of 40.41% from ¥11,149,720.14 in the previous year[6] - The company's basic earnings per share increased by 50.00% to ¥0.03, up from ¥0.02 in the same period last year[6] - In Q1 2023, the company achieved a revenue of 17.518 billion RMB, representing a year-on-year growth of 2.58%[17] - The net profit attributable to shareholders in Q1 2023 was 15.6549 million RMB, an increase of 40.41% compared to the same period last year[17] - Total operating costs for Q1 2023 were CNY 17,576,500,426.99, an increase from CNY 17,044,678,320.17 in Q1 2022, representing a growth of approximately 3.12%[35] - The company reported a total comprehensive income of CNY 13,947,843.42 for Q1 2023, compared to CNY 12,830,192.60 in Q1 2022, marking an increase of about 8.7%[36] Cash Flow and Financial Position - The net cash flow from operating activities improved to -¥801,245,598.78, a 32.75% reduction in losses compared to -¥1,191,402,355.34 in the same period last year[6] - The net cash flow from operating activities for Q1 2023 was -801,245,598.78, an improvement from -1,191,402,355.34 in Q1 2022, indicating a reduction in cash outflow[38] - The total cash inflow from operating activities was 21,381,354,028.73, compared to 18,606,675,308.77 in Q1 2022, showing growth in operational cash generation[38] - The total cash outflow from operating activities was 22,182,599,627.51, an increase from 19,798,077,664.11 in the previous year, indicating higher operational costs[38] - The cash and cash equivalents decreased to CNY 2,533,762,346.11 from CNY 2,753,973,619.75, a decline of about 7.98%[31] - The ending balance of cash and cash equivalents was 1,589,764,281.58, down from 2,249,131,730.86 in the previous year[39] Assets and Liabilities - Total assets at the end of Q1 2023 reached ¥9,689,589,496.22, marking a 24.34% increase from ¥7,792,783,558.14 at the end of the previous year[6] - The total current assets at the end of Q1 2023 amounted to CNY 7,500,128,242.38, up from CNY 6,129,987,554.72 at the beginning of the year, indicating a growth of about 22.34%[31] - The total liabilities as of March 31, 2023, were CNY 6,469,900,893.18, compared to CNY 4,515,488,519.32 at the start of the year, reflecting an increase of approximately 43.25%[32] - The company's total equity decreased slightly to CNY 3,219,688,603.04 from CNY 3,277,295,038.82, a decline of approximately 1.75%[32] Investments and Acquisitions - The company reported a significant increase in goodwill by 137.27% to ¥1,005,961,696.84 following the acquisition of Maikeluoluo Biotechnology[10] - The company has successfully completed the acquisition of Microlife Biotech, which specializes in over 50 types of biopesticides, expanding its product offerings in the agricultural sector[25] - The company’s investment income surged by 2634.94% to ¥74,773,994.00, driven by higher profits from derivative trading[10] Inventory and Borrowings - The company’s inventory increased by 124.04% to ¥2,222,055,904.07, attributed to increased stockpiling in response to commodity trading conditions[10] - The company’s short-term borrowings rose by 148.09% to ¥1,018,189,057.37, reflecting an increase in financing needs[10] Research and Development - Research and development expenses increased significantly to CNY 2,663,221.42 in Q1 2023 from CNY 210,789.67 in Q1 2022, indicating a rise of approximately 1165.4%[35] - The company has a strong focus on R&D, with over 40 patents related to biopesticides and has received multiple provincial and national awards for its innovations[23][24] Market and Customer Base - The company has established a strong customer base with over 400 upstream and downstream clients, including well-known enterprises like COFCO and Yihai Kerry[20] - The company has enhanced its agricultural promotion services, conducting over 200 promotional events nationwide, reaching over 100,000 views online[27] - The company has seen a rapid increase in the sales proportion of its formulation products, indicating a successful marketing strategy[27] Product Development - The company has introduced high-end products using Irish natural fermented cream and high-end tart crust oil, targeting the baking market[22] - The company aims to establish a mature biopesticide industrial system by 2025, focusing on R&D, production, and market promotion[26]